Home » Topics » BioWorld Science

BioWorld Science
RSS

New 5-HT1D antagonists from Pierre Fabre

April 26, 1996

SKB reports 5-HT2B/2C antagonists for CNS indications

April 26, 1996

Visipaque approved for marketing in U.S.

April 26, 1996

OraScan 100% sensitive in detecting oral squamous cell carcinomas

April 26, 1996

ISV-900 for diagnosis of glaucoma

April 26, 1996

Trinity Biotech begins marketing osteoporosis test in selected markets

April 26, 1996

Metasyn updates on MS-325 progress

April 26, 1996

AntiCancer's HDRA receives patent protection

April 26, 1996

Athena receives patent protection for ApoE in diagnosis of AD

April 26, 1996

Neoprobe, Peptor to codevelop peptide analogues for cancer diagnosis & treatment

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...